Table 2.
Plasma clinical chemistries
| placebo | 200 IU | 4000 IU | |
|---|---|---|---|
| PTH (pg/ml) | |||
| Pre | 36.1 (13.9) | 36.1 (14.6) | 31.4 (10.3) |
| 7-d | 40.7 (16.5) | 35.8 (16.4) | 30.8 (11.4) |
| 14-d | 38.5 (11.0) | 31.7 (13.1) | 30.3 (7.9) |
| 21-d | 35.0 (13.5) | 31.1 (11.0) | 25.9 (8.3) |
| 28-d | 35.5 (12.6) | 33.0 (17.9) | 32.1 (11.4) |
| calcium (mg/dl) | |||
| Pre | 9.22 (0.27) | 9.36 (0.26) | 9.32 (0.22) |
| 7-d | 9.06 (0.16) | 9.21 (0.38) | 9.38 (0.26) |
| 14-d | 9.15 (0.24) | 9.22 (0.27) | 9.41 (0.21) |
| 21-d | 9.09 (0.31) | 9.38 (0.29) | 9.30 (0.28) |
| 28-d | 9.16 (0.24) | 9.39 (0.35) | 9.35 (0.23) |
| creatinine (mg/dl) | |||
| Pre | 0.93 (0.08) | 0.91 (0.14) | 0.98 (0.17) |
| 7-d | 0.92 (0.08) | 0.97 (0.16) | 0.98 (0.15) |
| 14-d | 0.94 (0.09) | 0.92 (0.13) | 0.97 (0.17) |
| 21-d | 0.92 (0.13) | 0.92 (0.15) | 0.98 (0.15) |
| 28-d | 0.94 (0.16) | 0.91 (0.15) | 1.01 (0.13) |
| eGFR (ml/min/1.73 m2) | |||
| Pre | 90.9 (15.6) | 91.9 (12.6) | 87.7 (11.3) |
| 7-d | 91.1 (12.3) | 85.5 (15.0) | 87.5 (10.2) |
| 14-d | 89.1 (13.0) | 89.7 (9.2) | 89.5 (12.5) |
| 21-d | 91.6 (8.0) | 91.0 (13.2) | 88.0 (12.5) |
| 28-d | 90.2 (12.1) | 92.1 (14.3) | 84.7 (9.3) |
Data presented as mean (SD)